Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon (Q33535469)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon (English)

1 reference

Europe PubMed Central

27 July 2017

anti-retroviral agent

0 references

0 references

1 reference

based on heuristic

inferred from title

viral hepatitis

1 reference

based on heuristic

inferred from title

7

object named as

Henri Gwet

1 reference

Europe PubMed Central

27 July 2017

12

object named as

Eric Delaporte

0 references

Sinata Koulla-Shiro

8

object named as

Sinata Koulla-Shiro

1 reference

Europe PubMed Central

27 July 2017

Charles Kouanfack

3

object named as

Charles Kouanfack

1 reference

Europe PubMed Central

27 July 2017

Eitel Mpoudi-Ngolé

10

object named as

Eitel Mpoudi-Ngolé

1 reference

Europe PubMed Central

27 July 2017

Alexandra Calmy

6

object named as

Alexandra Calmy

1 reference

Europe PubMed Central

27 July 2017

Christian Laurent

2

object named as

Christian Laurent

1 reference

Europe PubMed Central

27 July 2017

4

object named as

Anke Bourgeois

1 reference

Europe PubMed Central

27 July 2017

5

object named as

Laura Ciaffi

1 reference

Europe PubMed Central

27 July 2017

author name string

Jules B Tchatchueng Mbougua

1

1 reference

Europe PubMed Central

27 July 2017

Jacques Ducos

9

1 reference

Europe PubMed Central

27 July 2017

Nicolas Molinari

11

1 reference

Europe PubMed Central

27 July 2017

language of work or name

0 references

publication date

1 March 2010

1 reference

Europe PubMed Central

27 July 2017

BMC Public Health

1 reference

Europe PubMed Central

27 July 2017

10

1 reference

Europe PubMed Central

27 July 2017

105

1 reference

Europe PubMed Central

27 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2458-10-105

0 references

High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Hepatitis B and long-term HIV outcomes in coinfected HAART recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Clinical implications of HIV and hepatitis B co-infection in Asia and Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Viral hepatitis and HIV in Africa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

HIV and hepatitis C virus co-infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

21 June 2018

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-10-105

21 January 2018

Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

31 October 2018

Antiretroviral drugs and liver injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

31 October 2018

Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

31 October 2018

Field assessment of generic antiretroviral drugs: a prospective cohort study in Cameroon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841671

31 October 2018

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20193053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/20193053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20193053

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2458-10-105

1 reference

Europe PubMed Central

27 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2458-10-105

9 September 2019

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33535469&oldid=1858534057"